SEARCH

SEARCH BY CITATION

References

  • Amir J, Louie L & Granoff DM (2005) Naturally acquired immunity to Neisseria meningitidis group A. Vaccine 23, 977983.
  • Broome CV, Rugh MA, Yada AA et al. (1983) Epidemic group C meningococcal meningitis in Upper Volta, 1979. Bulletin of the World Health Organization 61, 325330.
  • Chalmers AJ & O'Farrell WR (1916) Preliminary remarks upon epidemic cerebrospinal meningitis as seen in the Anglo-Egyptian Sudan. Journal of Tropical Medicine and Hygiene 29, 101129.
  • Davis LJ (1931) A bacteriological investigation of epidemic cerebrospinal meningitis in the southern Sudan. Transactions of the Royal Society of Tropical Medicine and Hygiene 24, 617622.
  • Danielson L & Mann E (1806) A history of a singular and very noted disease, which lately made its appearance in Medfield. Medical and Agricultural Register 1, 6569.
  • Decosas J & Koama J-BT (2002) Chronicle of an outbreak foretold: meningococcal meningitis W 135 in Burkina Faso. Lancet Infectious Diseases 2, 763765.
  • Denis F, Rey JL, Amadou A et al. (1982) Emergence of meningococcal meningitis caused by W135 serogroup in Africa. Lancet ii, 13351336.
  • Ensor H & Balfour A (1904) A case of cerebro-spinal meningitis. Journal of the Royal Army Medical Corps 3, 667670.
  • Gagneux SP, Hodgson A, Smith TA et al. (2002) Prospective study of serogroup X Neisseria meningitidis outbreak in northern Ghana. Journal of Infectious Diseases 185, 618626.
  • Greenwood B (1999) Meningococcal meningitis in Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene 93, 341353.
  • Greenwood BM, Bradley AK & Wall RA (1985) Meningococcal disease and season in sub-Sharan Africa. Lancet ii, 829830.
  • Greenwood BM, Cleland PG, Haggie MHK et al. (1979) An epidemic of meningococcal infection at Zaria, Northern Nigeria. 2. The changing clinical pattern. Transactions of the Royal Society of Tropical Medicine and Hygiene 73, 563566.
  • Horn AE (1908) Report on an investigation of cerebro-spinal fever in the northern territories of the Gold Coast in 1908. Journal of Tropical Medicine and Hygiene 11, 358365.
  • Kirk R (1950) Two epidemics of cerebrospinal meningitis. Sudan Notes and Records 31, 4353.
  • Jodar L, LaForce FM, Ceccarinn C, Aguado T & Granoff DM (2003) Meningococcal conjugate vaccines for Africa: a model for the development of new vaccines for poorest countries. Lancet 361, 19021904.
  • Kwara A, Adegbola RA, Corrah PT et al. (1998) Meningitis caused by a serogroup W135 clone of the ET-37 complex of Neisseria meningitidis in West Africa. Tropical Medicine and International Health 3, 742746.
  • Lapeyssonnie L (1963) La méningite cérébrospinale en Afrique. Bulletin of the World Health Organization 28 (Suppl.), 3114.
  • Leimkugel J, Forgor AA, Gagneux S et al. (2005) An outbreak of serotype 1 Streptococcus pneumoniae meningitis in northern Ghana with features that are characteristics of Neisseria meningitidis epidemics. Journal of Infectious Diseases 192, 192199.
  • McGahey K (1905a) Report on an outbreak of epidemic cerebro-spinal meningitis in Zungeru during February and March 1905. Journal of Tropical Medicine 8, 210216.
  • McGahey K (1905b) Report of the outbreak of cerebrospinal meningitis at Yola. Journal of Tropical Medicine 8, 216217.
  • Molesworth AM, Thomson MC, Connor SJ et al. (2002) Where is the meningitis belt? Defining an area at risk of epidemic meningitis in Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene 96, 242249.
  • Molesworth AM, Cuevas LE, Connor SJ, Morse AP & Thomson MC (2003) Environmental risk and meningitis epidemics in Africa. Emerging Infectious Diseases 9, 12871293.
  • Nathan N, Borel T, Djibo A et al. (2005) Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics; a randomised non-inferiority study. Lancet 366, 308313.
  • Nicolas P, Décousset L, Riglet V, Castelli P, Stor R & Blanchet G (2001) Clonal expansion of sequence type (ST-) 5 and emergence of ST-7 in serogroup A meningococci, Africa. Emerging Infectious Diseases 7, 849854.
  • Parent du Châtelet I, Traore Y, Gessner BD et al. (2005) Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing. Clinical Infectious Diseases 40, 1725.
  • Snape MD & Pollard AJ (2005) Meningococcal polysaccharide-protein conjugate vaccines. Lancet Infectious Diseases 5, 2130.
  • Tugwell P, Greenwood BM & Warrell DA (1976) Pneumococcal meningitis: a clinical and laboratory study. Quarterly Journal of Medicine 45, 583601.
  • Twumasi PA, Kumah S, Leach A et al. (1995) A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants. Journal of Infectious Diseases 171, 632638.
  • Vieusseux G (1806) Memoire sur la maladie qui regnéà Geneve au printemps de 1805. Journal de Médecine, de Chirurgie et de Pharmacologie (Bruxelles) 11, 5053.
  • Waddy BB (1957) African epidemic cerebrospinal meningitis. Journal of Tropical Medicine and Hygiene 60, 179189, 218–223.
  • Whittle HC, Evans-Jones G, Onyewotu I et al. (1975) Group C meningococcal meningitis in the northern savannah of Africa. Lancet 1, 1377.
  • Woods CW, Armstrong G, Sackey SO et al. (2000) Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa. Lancet 355, 3033.